ArticleBrain sciences2026
Quantitative Navigated Transcranial Magnetic Stimulation Motor Mapping and nTMS-Guided Corticospinal Tractography in Healthy Individuals and Patients with Motor-Eloquent Brain Tumors.
Article in Brain sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesNavigated transcranial magnetic stimulation (nTMS) enables presurgical motor mapping, while nTMS-seeded diffusion tensor imaging (DTI) delineates the corticospinal tract (CST). We compared cortical and tractography measures between healthy individuals and patients with motor-eloquent brain tumors and between patient hemispheres.
methodsTwenty healthy volunteers and 18 patients underwent first dorsal interosseous (FDI) mapping at 110% resting motor threshold (rMT). Motor map metrics, maximum FDI motor-evoked potential (MEP) amplitude, and nTMS-seeded CST measures were analyzed; hotspot and center-of-gravity (CoG) dispersion were assessed in common space. DTI metrics were available for 13 healthy volunteers and 13 patients.
resultsConsistent with previous nTMS literature, patients showed impaired motor performance and suprathreshold corticospinal output, with lower grip strength, maximum FDI MEP amplitude, and map volume than controls. rMT did not differ significantly, indicating that threshold excitability may be unrevealing despite motor system dysfunction. Notably, the contralateral patient hemisphere also differed from controls in grip strength, maximum FDI MEP amplitude, reconstructed CST fiber length, and mean axial diffusivity, while these measures did not differ significantly between the ipsilateral and contralateral patient hemispheres. CoG dispersion was greater in patients, whereas hotspot dispersion was not.
conclusionsThe study confirms tumor-associated impairment of motor performance and suprathreshold corticospinal output while identifying two potentially novel observations: abnormalities extending to the apparently unaffected hemisphere and increased heterogeneity of the amplitude-weighted motor map center. Notably, contralateral abnormalities may reflect bilateral network changes or patient-related factors, rather than isolated contralateral CST pathology. Independent healthy controls may therefore provide information not captured by within-patient hemispheric comparisons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.